Inconsistencies between species has stunted the progress of developing new analgesics. To increase the success of translating results between species, improved comparable models are required. Twelve rats received rectal balloon distensions on 2 different days separated by 24.3 (SD 24.6) days. Rectal balloon distensions were also performed in 18 humans (mean age: 34 yr; range: 21-56 yr; 12 men) on two separate occasions, separated by 9.3 (SD 5.5) days. In rats, cerebral evoked potentials (CEPs) were recorded by use of implanted skull-electrodes to distension pressure of 80 mmHg. In humans surface electrodes and individualized pressure, corresponding to pain detection threshold, were used. Comparison of morphology was assessed by wavelet analysis. Within-and between-day reproducibility was assessed in terms of latencies, amplitudes, and frequency content. In rats CEPs showed triphasic morphology. No differences in latencies, amplitudes, and power distribution were seen within or between days (all P Ն 0.5). Peak-to-peak amplitude between the first positive and negative potential were the most reproducible characteristic within and between days (evaluated by intraclass correlation coefficients, ICC) (ICC ϭ 0.99 and ICC ϭ 9.98, respectively). In humans CEPs showed a triphasic morphology. No differences in latencies, amplitudes, or power distribution were seen within or between days (all P Ն 0.2). Latency to the second negative potential (ICC ϭ 0.98) and the second positive potential (ICC ϭ 0.95) was the most reproducible characteristic within and between days. A unique and reliable translational platform was established assessing visceral sensitivity in rats and humans, which may improve the translational process of developing new drugs targeting visceral pain.translation; mechanical rectal distension; evoked potentials; reproducibility DEVELOPMENT OF NEW ANALGESICS is very costly. A main contributing factor to this cost is thought to be a result of high attrition rates (27). One reason for these high attrition rates could be inconsistencies between species, resulting in inhibited progress of developing new analgesics. The relatively inadequate predictive value of preclinical animal models used to test pharmacological compounds before using them in human clinical trials increases the demand of objective translational comparable models.Because the underlying pathophysiology remains unknown in many pain and central nervous system disorders, the construct validity of animal models may be limited and unlikely to reflect the clinical picture in humans that they attempt to model. Hence, an increased understanding of the underlying pathophysiological mechanisms will enhance the possibility of creating animal models with better construct validity. However, this remains challenging and an ideal model needs to be accurate, responsive, sensitive to therapy, and better than existing models.An alternative method to increase the predictive values of animal models would be to establish translational comparable experimental methods....